Maveral en es it fr

Maveral Brand names, Maveral Analogs

Maveral Brand Names Mixture

  • No information avaliable

Maveral Chemical_Formula


Maveral RX_link

Maveral fda sheet

Maveral FDA

Maveral msds (material safety sheet)

Maveral MSDS

Maveral Synthesis Reference

Neth. pat. Appl. 7503310; H. B. A. Welle, V. Classen, U.S. pat. 4085225

Maveral Molecular Weight

318.335 g/mol

Maveral Melting Point

120-122.5 oC

Maveral H2O Solubility

No information avaliable

Maveral State


Maveral LogP

No information avaliable

Maveral Dosage Forms


Maveral Indication

For treatment of depression and for Obsessive Compulsive Disorder (OCD)

Maveral Pharmacology

Fluvoxamine is one of a class of antidepressants known as selective serotonin reuptake inhibitors (SSRIs). It is used to treat the depression associated with mood disorders. It is also used on occassion in the treatment of body dysmorphic disorder and anxiety. The antidepressant, antiobsessive-compulsive, and antibulimic actions of Fluvoxamine are presumed to be linked to its inhibition of CNS neuronal uptake of serotonin. In vitro studies show that Fluvoxamine is a potent and selective inhibitor of neuronal serotonin reuptake and has only very weak effects on norepinephrine and dopamine neuronal reuptake. Fluvoxamine has no significant affinity for adrenergic (alpha1, alpha2, beta), cholinergic, GABA, dopaminergic, histaminergic, serotonergic (5HT1A, 5HT1B, 5HT2), or benzodiazepine receptors; antagonism of such receptors has been hypothesized to be associated with various anticholinergic, sedative, and cardiovascular effects for other psychotropic drugs. The chronic administration of Fluvoxamine was found to downregulate brain norepinephrine receptors, as has been observed with other drugs effective in the treatment of major depressive disorder. Fluvoxamine does not inhibit monoamine oxidase.

Maveral Absorption

Well absorbed, bioavailability of fluvoxamine maleate is 53%.

Maveral side effects and Toxicity

Side effects include anorexia, constipation, dry mouth, headache, nausea, nervousness, skin rash, sleep problems, somnolence, liver toxicity, mania, increase urination, seizures, sweating increase, tremors, or Tourette's syndrome.

Maveral Patient Information

No information avaliable

Maveral Organisms Affected

Humans and other mammals